Charles Li
Director/Board Member chez EKSO BIONICS HOLDINGS, INC.
Fortune : 52 075 $ au 29/02/2024
Profil
Charles Li is on the board of Ekso Bionics Holdings, Inc. and Chief Business Officer for Angel Pharmaceuticals Co., Ltd.
He received a doctorate from Harvard University and an undergraduate degree from Xi'an Jiaotong University.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
14/04/2023 | 27 408 ( 0,15% ) | 52 075 $ | 29/02/2024 |
Postes actifs de Charles Li
Sociétés | Poste | Début |
---|---|---|
EKSO BIONICS HOLDINGS, INC. | Director/Board Member | 11/03/2018 |
Angel Pharmaceuticals Co., Ltd.
Angel Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Angel Pharmaceuticals Co., Ltd. operates as a biopharmaceutical company which develops medicines for treatment of cancer, autoimmune and infectious diseases. The company was founded by Richard Miller and Ted Wang on October 5, 2020 and is headquartered in Shanghai, China. | Corporate Officer/Principal | 10/10/2020 |
Formation de Charles Li
Harvard University | Doctorate Degree |
Xi'an Jiaotong University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
EKSO BIONICS HOLDINGS, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Angel Pharmaceuticals Co., Ltd.
Angel Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Angel Pharmaceuticals Co., Ltd. operates as a biopharmaceutical company which develops medicines for treatment of cancer, autoimmune and infectious diseases. The company was founded by Richard Miller and Ted Wang on October 5, 2020 and is headquartered in Shanghai, China. | Health Technology |